Cargando…

Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures

INTRODUCTION: New initiatives presented by the World Health Organization (WHO) and the Joint United Nations Program on HIV and AIDS , such as 90-90-90, test and treat, preventive treatment, and best international practices related to the introduction of rapid human immunodeficiency virus (HIV) testi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alibayeva, KO, Saparbekov, MK, Baiserkin, BS, Abishev, AT, Tazhibaeva, GH, Kasymbekova, SZ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745404/
https://www.ncbi.nlm.nih.gov/pubmed/31564992
http://dx.doi.org/10.2147/HIV.S212718
_version_ 1783451539531104256
author Alibayeva, KO
Saparbekov, MK
Baiserkin, BS
Abishev, AT
Tazhibaeva, GH
Kasymbekova, SZ
author_facet Alibayeva, KO
Saparbekov, MK
Baiserkin, BS
Abishev, AT
Tazhibaeva, GH
Kasymbekova, SZ
author_sort Alibayeva, KO
collection PubMed
description INTRODUCTION: New initiatives presented by the World Health Organization (WHO) and the Joint United Nations Program on HIV and AIDS , such as 90-90-90, test and treat, preventive treatment, and best international practices related to the introduction of rapid human immunodeficiency virus (HIV) testing in clinics, and field conditions, including self-testing, predetermined the introduction of NGO-based rapid HIV testing in the Republic of Kazakhstan nongovernmental organizations (NGOs). This work presents the results of a comprehensive study conducted about the possible introduction of NGO-based rapid HIV testing in the country. It should be noted that 32,573 HIV infections have been diagnosed in Kazakhstan (prevalence of 117.7 per 100,000 people) from 1987 to 2018. Most of these new cases are diagnosed among “key” population groups, such as people who use injectable drugs, sex workers, men who have sex with men, those who rely mainly on NGOs, and those who prefer to deal with an organization such as an NGO, which makes it possible to introduce NGO-based rapid HIV testing in Kazakhstan. METHODS: In this work, we used the following rapid HIV tests: Alere DetermineTM HIV ½ Ag/Ab Combo, Hexagon HIV 1+2, Abon HIV ½, HIV 1,2 Han Medtest, and Geenius HIV1/2 Confirmatory. RESULTS: The study of the rapid tests, including their diagnostic patterns, conducted in Kazakhstan shows that five rapid HIV tests completely meet the WHO’s requirements (sensitivity>99%; specificity>98%). These are Alere DetermineTM HIV ½ Ag/Ab Combo, Hexagon HIV 1+2, Abon HIV ½, HIV 1,2 Han Medtest, and Geenius HIV1/2 Confirmatory. The study of legal and social problems associated with rapid HIV testing in NGOs shows that HIV-related medical examination and counseling carried out in Kazakhstan, including those by rapid methods, are governed by corresponding laws and normative legal documents. CONCLUSION: It has been established that there are social barriers that interfere with rapid HIV testing. In view of this, services associated with NGO-based rapid HIV testing shall be rendered with the use of a social and legal protection mechanism for those under examination.
format Online
Article
Text
id pubmed-6745404
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67454042019-09-27 Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures Alibayeva, KO Saparbekov, MK Baiserkin, BS Abishev, AT Tazhibaeva, GH Kasymbekova, SZ HIV AIDS (Auckl) Original Research INTRODUCTION: New initiatives presented by the World Health Organization (WHO) and the Joint United Nations Program on HIV and AIDS , such as 90-90-90, test and treat, preventive treatment, and best international practices related to the introduction of rapid human immunodeficiency virus (HIV) testing in clinics, and field conditions, including self-testing, predetermined the introduction of NGO-based rapid HIV testing in the Republic of Kazakhstan nongovernmental organizations (NGOs). This work presents the results of a comprehensive study conducted about the possible introduction of NGO-based rapid HIV testing in the country. It should be noted that 32,573 HIV infections have been diagnosed in Kazakhstan (prevalence of 117.7 per 100,000 people) from 1987 to 2018. Most of these new cases are diagnosed among “key” population groups, such as people who use injectable drugs, sex workers, men who have sex with men, those who rely mainly on NGOs, and those who prefer to deal with an organization such as an NGO, which makes it possible to introduce NGO-based rapid HIV testing in Kazakhstan. METHODS: In this work, we used the following rapid HIV tests: Alere DetermineTM HIV ½ Ag/Ab Combo, Hexagon HIV 1+2, Abon HIV ½, HIV 1,2 Han Medtest, and Geenius HIV1/2 Confirmatory. RESULTS: The study of the rapid tests, including their diagnostic patterns, conducted in Kazakhstan shows that five rapid HIV tests completely meet the WHO’s requirements (sensitivity>99%; specificity>98%). These are Alere DetermineTM HIV ½ Ag/Ab Combo, Hexagon HIV 1+2, Abon HIV ½, HIV 1,2 Han Medtest, and Geenius HIV1/2 Confirmatory. The study of legal and social problems associated with rapid HIV testing in NGOs shows that HIV-related medical examination and counseling carried out in Kazakhstan, including those by rapid methods, are governed by corresponding laws and normative legal documents. CONCLUSION: It has been established that there are social barriers that interfere with rapid HIV testing. In view of this, services associated with NGO-based rapid HIV testing shall be rendered with the use of a social and legal protection mechanism for those under examination. Dove 2019-09-11 /pmc/articles/PMC6745404/ /pubmed/31564992 http://dx.doi.org/10.2147/HIV.S212718 Text en © 2019 Alibayeva et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Alibayeva, KO
Saparbekov, MK
Baiserkin, BS
Abishev, AT
Tazhibaeva, GH
Kasymbekova, SZ
Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title_full Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title_fullStr Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title_full_unstemmed Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title_short Study of the possibility of introduction of Kazakhstan NGO-based rapid HIV testing procedures
title_sort study of the possibility of introduction of kazakhstan ngo-based rapid hiv testing procedures
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745404/
https://www.ncbi.nlm.nih.gov/pubmed/31564992
http://dx.doi.org/10.2147/HIV.S212718
work_keys_str_mv AT alibayevako studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures
AT saparbekovmk studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures
AT baiserkinbs studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures
AT abishevat studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures
AT tazhibaevagh studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures
AT kasymbekovasz studyofthepossibilityofintroductionofkazakhstanngobasedrapidhivtestingprocedures